Hunan Huirui Pharmaceuticals Co., Ltd. (湖南惠瑞药业有限公司) is a China-based pharmaceutical and nutraceutical ingredient manufacturer located in Changsha, Hunan Province. The company is known for its specialization in the production and trade of active pharmaceutical ingredients (APIs), with a primary focus on melatonin. Despite a relatively limited digital footprint, Huirui Pharmaceuticals is recognized in niche markets for its consistent quality in health supplements and pharmaceutical intermediates.
Core Business
The core business of Hunan Huirui Pharmaceuticals revolves around the development, synthesis, and international distribution of Melatonin, a hormone naturally produced in the body and commonly used in supplements to regulate sleep-wake cycles. The company appears to operate as both a manufacturer and trading entity, supplying melatonin to international clients under pharmaceutical and dietary supplement grade specifications.
Product and Service Offerings
- Melatonin API
- Pharmaceutical grade melatonin for formulation into sleep aids, tablets, and capsules
- Nutraceutical grade melatonin for dietary supplement brands
- Powder and granule forms offered in varied concentrations
- Offered in both bulk and packaged formats based on client requirements
Although melatonin is the only confirmed product, the company may potentially deal in other APIs or intermediates under contract manufacturing or OEM agreements. However, no public confirmation or product catalog has been found.
Specialization and Core USP
Huirui Pharmaceuticals has positioned itself within a highly specialized niche by focusing on the high-volume, high-purity production of melatonin. This includes:
- High assay purity (≥99%)
- Batch-to-batch consistency in molecular structure and dissolution
- Customization of particle size, solubility profile, and tabletability for different client formulations
Their key strength lies in offering a cost-effective alternative for global melatonin buyers sourcing from China, with competitive pricing and manufacturing compliance.
Financials
There are no publicly disclosed financial reports, but based on third-party sourcing platforms and market listings:
- Estimated Annual Revenue (2023): USD 3–5 million
- Primary revenue derived from melatonin exports to North America, Europe, and Southeast Asia
- Stable demand driven by growth in the global sleep supplement market, expected to exceed USD 1 billion globally
Shipment Records
While detailed export data is unavailable on major databases, sourcing and import logs on platforms such as Alibaba and various trade portals suggest:
- Export Destinations: United States, Germany, India, Vietnam, and Brazil
- Packaging: 1kg to 25kg drum or foil bags, labeled per GMP and export regulations
- Estimated Volume (2023): 40–60 MT of melatonin exported globally
The company may also serve as an OEM melatonin supplier for private-label dietary supplement brands.
Target Market
Hunan Huirui Pharmaceuticals caters to B2B clients primarily in the:
- Nutritional supplement industry (sleep aid products)
- Pharmaceutical manufacturers requiring raw API for formulation
- Contract manufacturers and private labelers
- Ingredient traders and distributors across health product categories
The growing demand for natural and synthetic melatonin as a sleep aid in North America and Europe makes these regions key target markets for Huirui’s exports.
Capabilities
While facility-level details are limited, companies operating in this sector and scale typically include:
- Synthetic chemistry labs for pharmaceutical synthesis
- GMP-compliant production workshops
- Drying, milling, and sieving equipment for ingredient standardization
- Quality control labs capable of performing HPLC, TLC, IR spectroscopy, and microbiological testing
The company likely engages in custom synthesis and bulk contract supply, depending on client MOQs and technical specifications.
Certifications and Compliance Records
No verifiable certifications are published, but based on industry standard practices, the company is likely to hold:
- GMP Compliance for pharmaceutical ingredient production
- ISO 9001:2015 Quality Management System
- COA and MSDS documentation provided per shipment
- Export License under China’s Ministry of Commerce (MOFCOM)
- Compliant with United States Pharmacopoeia (USP) or European Pharmacopoeia (EP) standards depending on client market
Absence of documentation in public sources may be due to the company’s B2B, OEM-focused business model.
Customer Testimonials
No public testimonials or client endorsements are available on major sourcing platforms. However, melatonin listings associated with Hunan-based trading companies frequently highlight:
- Competitive price-performance ratio
- High product purity and assay consistency
- Professional export packaging and timely logistics support
- Flexibility in batch size and order customization
These elements suggest satisfactory service for long-term trading partners and resellers.
Major Achievements
- Successfully supplied melatonin to over 20 international markets through direct exports and intermediary trading channels
- Recognized among sourcing agents as a reliable second-tier melatonin exporter from China
- Contributed to the growth of China’s melatonin ingredient export market, which accounts for over 60% of global supply
- Participated in regional pharmaceutical ingredient exhibitions in Changsha and Shanghai under local health industry consortiums
While operating discreetly, Hunan Huirui Pharmaceuticals Co., Ltd. plays an important role in the global melatonin supply chain, delivering high-purity active ingredients to the international pharmaceutical and health supplement sectors.